TD Waterhouse Canada Inc.
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1999606
TORONTO, A6
Position in REGN
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$2,420,681
-$2,871,259 QoQ
Shares Held
3,133
-54.3% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
18 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026TD Waterhouse Canada Inc. holds $47,771,505 across 78 Biotechnology names. REGN ranks #3 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABCL |
AbCellera Biologics Inc.
|
9,564,659 | $33,380,659 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
13,774 | $6,150,641 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
3,133 | $2,420,681 | |
| 4 | RPRX |
Royalty Pharma plc
|
36,933 | $1,771,676 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,971 | $652,144 | |
| 6 | CNTA |
Centessa Pharmaceuticals plc
|
15,595 | $619,433 | |
| 7 | ONC |
BeOne Medicines Ltd.
|
2,032 | $603,443 | |
| 8 | EPRX |
Eupraxia Pharmaceuticals Inc.
|
81,725 | $591,689 |
All Filings in REGN
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,420,681 | 3,133 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $5,291,940 | 6,856 | Shares | Defined | 2026-01-27 | |
| 2025-09-30 | $5,170,634 | 9,196 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $2,421,825 | 4,613 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $17,124 | 27 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $37,753 | 53 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $4,512,973 | 4,293 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $4,946,147 | 4,706 | Shares | Defined | 2024-11-12 | |
| 2024-03-31 | $4,628,614 | 4,809 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $3,449,923 | 3,928 | Shares | Defined | 2024-05-10 | |
| 2023-09-30 | $3,783,970 | 4,598 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,357,322 | 1,889 | Shares | Defined | 2023-11-13 | |
| 2023-03-31 | $1,490,509 | 1,814 | Shares | Defined | 2023-11-13 | |
| 2022-12-31 | $1,367,223 | 1,895 | Shares | Defined | 2023-11-13 | |
| 2022-09-30 | $1,555,468 | 2,258 | Shares | Defined | 2023-11-13 | |
| 2022-06-30 | $1,013,196 | 1,714 | Shares | Defined | 2023-11-13 | |
| 2022-03-31 | $1,157,281 | 1,657 | Shares | Defined | 2023-11-13 | |
| 2021-12-31 | $980,750 | 1,553 | Shares | Defined | 2023-11-13 | |
| No filing history on record for this holder in this stock. | ||||||